Literature DB >> 9700116

Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome.

D K Madtes1, G Rubenfeld, L D Klima, J A Milberg, K P Steinberg, T R Martin, G Raghu, L D Hudson, J G Clark.   

Abstract

The acute respiratory distress syndrome (ARDS) frequently results in a fibroproliferative response that precludes effective alveolar repair. Transforming growth factor-alpha (TGF-alpha), a potent epithelial and mesenchymal cell mitogen, may modulate the response to lung injury. In this study, we determined whether bronchoalveolar lavage fluid (BALF) concentrations of TGF-alpha are increased during the first 2 wk after the onset of ARDS and, if so, whether increased TGF-alpha levels in lavage fluid are associated with increased levels of procollagen peptide III (PCP III), a biological marker of fibroproliferation, and with increased fatality rates. We enrolled 74 consecutive patients with ARDS prospectively identified on admission to the intensive care unit of a tertiary care hospital, and 11 patients with chronic interstitial lung disease. Thirteen healthy volunteers served as control subjects. TGF-alpha concentrations were measured in BALF recovered on Days 3, 7, and 14 after the onset of ARDS (total of 130 lavage samples). TGF-alpha was detected in the lavage fluid of 90% of patients with ARDS (67 of 74), and in 100% of patients with idiopathic pulmonary fibrosis (IPF) (10 of 10), but in none of 13 normal volunteers. At each day tested, the median lavage TGF-alpha level of patients with ARDS was significantly higher than that of normals. The overall fatality rate was 45% (33 of 74 patients). In a univariate analysis, the median TGF-alpha levels in nonsurvivors were 1.5-fold higher at Day 7 (p = 0.06) and 1.8-fold higher at Day 14 (p = 0.048). The fatality rate was 4 times higher (CI 1.6, 17.5) for patients with both increased lavage TGF-alpha and PCP III concentrations at Day 7 than for patients with low TGF-alpha and PCP III values, indicating a synergistic relationship between TGF-alpha and PCP III. We conclude that increased levels of TGF-alpha in BALF are common in patients with ARDS and that lavage TGF-alpha is associated with a marker of the fibroproliferative response in sustained ARDS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700116     DOI: 10.1164/ajrccm.158.2.9711112

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  31 in total

Review 1.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

2.  Successful treatment of gefitinib-induced acute interstitial pneumonitis with corticosteroid and non-invasive BIPAP-ventilation.

Authors:  Yalei Zhang; Haihong Yang; Meiling Zhao; Jianxing He
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

Review 3.  Signaling pathways in the epithelial origins of pulmonary fibrosis.

Authors:  William D Hardie; James S Hagood; Vrushank Dave; Anne-Karina T Perl; Jeffrey A Whitsett; Thomas R Korfhagen; Stephan Glasser
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

4.  Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema.

Authors:  M Schläpfer; A C Leutert; S Voigtsberger; R A Lachmann; C Booy; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

5.  Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis.

Authors:  Satish K Madala; Thomas R Korfhagen; Stephanie Schmidt; Cynthia Davidson; Ramakrishna Edukulla; Machiko Ikegami; Shelia M Violette; Paul H Weinreb; Dean Sheppard; William D Hardie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-07       Impact factor: 5.464

6.  Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.

Authors:  A B Rice; C R Moomaw; D L Morgan; J C Bonner
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 7.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

Review 8.  The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.

Authors:  Ellen L Burnham; William J Janssen; David W H Riches; Marc Moss; Gregory P Downey
Journal:  Eur Respir J       Date:  2013-03-21       Impact factor: 16.671

9.  Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis.

Authors:  Shin-Hwa Lee; An-Soo Jang; Young-Eun Kim; Ji-Yeon Cha; Tae-Hoon Kim; Seok Jung; Seong-Kyu Park; You-Kyoung Lee; Jong-Ho Won; Yong-Hoon Kim; Choon-Sik Park
Journal:  Respir Res       Date:  2010-02-08

10.  Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis.

Authors:  William D Hardie; Thomas R Korfhagen; Maureen A Sartor; Adrienne Prestridge; Mario Medvedovic; Timothy D Le Cras; Machiko Ikegami; Scott C Wesselkamper; Cynthia Davidson; Maggie Dietsch; William Nichols; Jeffrey A Whitsett; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2007-05-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.